Home MC10 Inc

MC10 Inc

Multiple Sclerosis Clinical Trials Using the BioStamp nPoint® System

MC10, Inc., a healthcare technology company specializing in wearable digital health sensors, and AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced today that the companies are working together on clinical trials designed to explore a range of outcome measures in patients with multiple sclerosis (MS) using the BioStamp nPoint® system.

MC10 and the Shirley Ryan AbilityLab Initiate Research Collaboration

HOME Together Will Develop Novel Solutions for Neurodegenerative Disease & Motion Disability Rehabilitation MC10, Inc., the company delivering wearable sensor systems for personalized...

Must Read

Joe Montana Professional Football Hall of Famer Joins Stimwave Technologies As Official Spokesperson

“After years of dealing with the residual effects of my professional football career, I am excited to have found this battery-free, minimally-invasive alternative to opioids that relieves chronic pain and I’m eager to help other chronic pain sufferers receive this life-changing micro-implant,” said Montana.

Interventional Neurology: Carotid Artery Stents and Embolic Protection Systems Market Forecast

This medical market and technology report provides a comprehensive discussion of the global market for carotid artery stents and embolic protection systems.

Thirdwayv Appoints Dr. Aiman Abdel-Malek as Executive Chairman of Its Newly Formed Advisory Board

“We are very excited about having Dr. Abdel-Malek take the helm of our newly created Advisory Board,” said James Kamke, chief executive officer, Thirdwayv.